Rauvolfia serpentina (Indian Snakeroot) — Hermetica Encyclopedia
Herbs (Global Traditional) · Ayurveda

Rauvolfia serpentina (Indian Snakeroot)

Provisional Strong Scorebotanical

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Indian snakeroot (Rauvolfia serpentina) contains reserpine and related alkaloids that deplete neurotransmitters like norepinephrine and serotonin from nerve terminals. These compounds traditionally support cardiovascular health by reducing sympathetic nervous system activity, though clinical evidence remains limited.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryHerbs (Global Traditional)
GroupAyurveda
Public Score StatusProvisional Strong
Primary KeywordIndian snakeroot benefits
Rauvolfia serpentina (Indian Snakeroot) — botanical
Rauvolfia serpentina (Indian Snakeroot) — botanical close-up

Origin & History

Rauvolfia serpentina (Indian Snakeroot) — origin
Natural habitat

Rauwolfia serpentina, commonly known as Indian snakeroot, is an evergreen shrub native to the Indian subcontinent and member of the Apocynaceae (milkweed) family. The root is the primary medicinal component, typically ground into powder or processed into tablets and capsules, containing approximately 50 identified alkaloid compounds including reserpine, rescinnamine, and deserpidine.

Rauwolfia serpentina has been used extensively in Ayurvedic medicine as a distinctive medicinal shrub for treating insomnia, anxiety, high blood pressure, and cardiovascular diseases. The plant is also utilized in broader Asian traditional medicine systems.Traditional Medicine

Research Narrative (Provisional)

The research dossier does not contain specific human clinical trials, randomized controlled trials, or meta-analyses with PubMed PMIDs. WebMD explicitly states there is 'no good scientific evidence' to support the traditional uses of Rauwolfia serpentina.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Rauvolfia serpentina is not consumed as a food or dietary source; it is a medicinal plant valued exclusively for its bioactive alkaloid profile rather than macronutrient or micronutrient content. The root bark contains over 50 identified indole alkaloids, with the following being the most pharmacologically significant: Primary Alkaloids (concentrated in root bark): • Reserpine: ~0.1–0.2% of dried root weight (range 0.05–0.35% depending on cultivar, geography, and harvest time); a trimethoxybenzoyl ester of methyl reserpate; acts as an irreversible inhibitor of vesicular monoamine transporter 2 (VMAT2), depleting catecholamines and serotonin from nerve terminals • Ajmaline: ~0.2–0.5% of dried root; a class IA antiarrhythmic alkaloid that blocks sodium channels • Ajmalicine (δ-yohimbine/raubasine): ~0.1–0.4%; an α1-adrenergic antagonist with cerebral vasodilatory properties • Serpentine: ~0.1–0.3%; topoisomerase II inhibitor with anticancer research interest • Yohimbine: trace to ~0.05%; α2-adrenergic antagonist • Deserpidine: structurally related to reserpine, present in minor quantities (~0.01–0.05%) • Rescinnamine: ~0.02–0.1%; hypotensive alkaloid similar in action to reserpine Other Notable Alkaloids: Serpentinine, sarpagine, thebaine, corynanthine, isoajmaline, chandrine, and rauwolfine — each typically <0.05% of dried root. Total Alkaloid Content: Approximately 0.8–2.0% of dried root by weight, depending on plant part (root bark > whole root > stem > leaves), plant age (3–4 year old roots preferred), geographic origin (Indian subcontinent specimens generally highest), and extraction method. Non-Alkaloid Constituents: • Phytosterols (β-sitosterol, stigmasterol): trace amounts • Oleic acid, stearic acid: present in root lipid fraction • Tannins and phenolic compounds: minor quantities • Carbohydrates/starch: present in root matrix but not nutritionally relevant • No significant vitamin, mineral, dietary fiber, or protein content of nutritional importance Bioavailability Notes: • Reserpine is highly lipophilic (logP ~3.6) with good oral bioavailability (~50–70% in animal models); it binds irreversibly to VMAT2, giving it an exceptionally long duration of action (days to weeks) despite a plasma half-life of ~33 hours • Ajmaline has moderate oral bioavailability (~20–30%) and undergoes significant hepatic first-pass metabolism via CYP2D6; poor metabolizers may experience elevated plasma levels • Whole-root preparations (as used in Ayurveda) deliver a complex alkaloid mixture; the plant matrix may modulate absorption kinetics compared to isolated reserpine, potentially resulting in a slower, more gradual onset — though this has not been rigorously studied in pharmacokinetic trials • Traditional Ayurvedic preparations (churna/powder, decoction) use doses of dried root typically ranging from 200–600 mg/day, delivering roughly 0.2–1.2 mg total reserpine equivalent Important Note: This plant is classified as a potent medicinal herb, not a nutritional supplement. All alkaloids are pharmacologically active at low doses, and reserpine has a very narrow therapeutic index. The plant is listed as endangered (CITES Appendix II) due to overharvesting.

Reported Mechanism (Provisional)

Mechanism of Action

Reserpine and related alkaloids in Indian snakeroot deplete monoamine neurotransmitters (norepinephrine, dopamine, serotonin) by blocking their uptake into synaptic vesicles. This depletion reduces sympathetic nervous system activity, leading to vasodilation and decreased heart rate. Ajmaline alkaloid acts as a sodium channel blocker, potentially affecting cardiac rhythm through Class IA antiarrhythmic activity.

Clinical Narrative (Provisional)

Limited modern clinical research exists on Rauvolfia serpentina as a whole plant extract. Historical studies from the 1950s-60s examined isolated reserpine for hypertension, showing blood pressure reductions of 10-20 mmHg in small trials of 20-50 participants. Most current evidence relies on traditional use documentation rather than randomized controlled trials. No recent large-scale studies have validated the cardiovascular or anxiolytic effects of standardized Indian snakeroot preparations.

Also Known As

Rauwolfia serpentinaIndian snakerootSarpagandhaChandrikaDevil pepperSerpentwoodRauvolfiaPagla-ka-dawa

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.